Loading…
Sensei Biotherapeutics, Inc. is projected to rise to $23.04 by 2027, a +38% move from its current price of $16.65. SNSE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $15.81 | $16.64 | $17.51 | -0.08% |
| May 30 | $15.46 | $16.62 | $17.87 | -0.17% |
| May 31 | $15.20 | $16.61 | $18.15 | -0.25% |
| Jun 1 | $14.98 | $16.59 | $18.38 | -0.34% |
| Jun 2 | $14.79 | $16.58 | $18.59 | -0.42% |
| Jun 3 | $14.61 | $16.57 | $18.78 | -0.51% |
| Jun 4 | $14.46 | $16.55 | $18.95 | -0.59% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.46 | $16.55 | $18.95 | -0.59% |
| Week 2 | $13.59 | $16.45 | $19.93 | -1.17% |
| Week 3 | $12.94 | $16.36 | $20.68 | -1.76% |
| Week 4 | $12.40 | $16.26 | $21.32 | -2.34% |
| Week 5 | $11.94 | $16.17 | $21.88 | -2.91% |
| Week 6 | $11.53 | $16.07 | $22.39 | -3.48% |
| Week 7 | $11.16 | $15.98 | $22.86 | -4.05% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sensei Biotherapeutics, Inc. is a clinical-stage biotechnology company engaged in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer, and Solnerstotug, an active monoclonal antibody in clinical Phase 1/2 targeting the immune checkpoint VISTA for solid tumors.
Its pipeline includes SNS-102 and SNS-103, active monoclonal antibodies in early development for solid tumors, as well as SNS-201, a bispecific antibody targeting CD28. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland, having been formerly known as Panacea Pharmaceuticals, Inc.
SNSE is the ticker for Sensei Biotherapeutics, Inc. It is currently priced at $17.79 per share, with a market capitalization of $23.87M and a rank of 4890. The stock sits in a price range and shows a path forward reflected in the forecasted numbers.
The 2026 avg price is $17.79, with the forecast climbing in subsequent years to higher averages such as $24.82 in 2027 and $63.73 by 2050, while the implied max values rise to $40.88 in 2030, $103.54 in 2040, and $146.57 in 2050.
A major floor 65.4% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.1% away) — a key level to hold.
The nearest ceiling, 95.9% above — a clean break opens room to run.
A major ceiling 128.6% above — clearing it would confirm fresh momentum.
Key SNSE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SNSE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $17.21 | Sell | $17.29 | Sell |
| MA 10 | $18.41 | Sell | $18.60 | Sell |
| MA 20 | $21.67 | Sell | $21.15 | Sell |
| MA 50 | $26.94 | Sell | $23.87 | Sell |
| MA 100 | $22.40 | Sell | $22.17 | Sell |
| MA 200 | $15.82 | Buy | $18.30 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 27.31 | Buy |
| Stoch RSI (14) | 30.46 | Neutral |
| CCI (20) | -97.71 | Neutral |
| Williams %R (14) | -97.53 | Info |
| MACD (12,26,9) | -0.39 | Sell |
| ROC (12) | -28.85 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 2.47 | Buy |
| TRIX (15) | -1.52 | Sell |
| Awesome (5,34) | -8.09 | Sell |
| Ultimate (7,14,28) | 19.54 | Buy |
| Momentum (10) | -4.35 | Sell |
| Aroon Osc (25) | -88.00 | Sell |
| Hull MA (9) | 16.47 | Buy |
| ADX (14) | 32.50 | Sell |
| ATR (14) | 0.97 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 30. The 50-day simple moving average is $27.53 and the 200-day simple moving average is $15.72. Support is at $16.77 and resistance at $32.62. Over the last 30 days, the price range has been between $12.62 and $25.07.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $8.75 | $16.65 | $22.17 | 0% | Neutral | |
| $16.73 | $23.04 | $34.32 | +38% | Bullish | |
| $14.71 | $21.44 | $33.88 | +29% | Bullish | |
| $14.69 | $22.48 | $37.19 | +35% | Bullish | |
| $13.76 | $22.00 | $37.82 | +32% | Bullish | |
| $11.19 | $18.64 | $33.13 | +12% | Neutral | |
| $13.14 | $22.77 | $41.67 | +37% | Bullish | |
| $15.15 | $27.28 | $51.26 | +64% | Bullish | |
| $16.09 | $30.06 | $57.86 | +81% | Bullish | |
| $17.21 | $33.33 | $65.59 | +100% | Bullish | |
| $19.54 | $43.42 | $93.63 | +161% | Bullish | |
| $25.73 | $57.17 | $131.49 | +243% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $8.75 | $16.65 | $19.90 | +0.00% |
| June 2026 | $13.95 | $16.70 | $20.69 | +0.29% |
| July 2026 | $12.67 | $15.42 | $19.58 | -7.68% |
| August 2026 | $12.53 | $15.44 | $19.97 | +0.16% |
| September 2026 | $12.89 | $16.05 | $21.08 | +3.97% |
| October 2026 | $12.22 | $15.37 | $20.46 | -4.26% |
| November 2026 | $11.82 | $14.99 | $20.19 | -2.46% |
| December 2026 | $12.73 | $16.29 | $22.17 | +8.64% |
Click any year to see its month-by-month SNSE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Sensei Biotherapeutics, Inc.'s 2026 outlook centres on $16.65, within a $8.75 to $22.17 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SNSE could reach as high as $34.32, with a base case around $23.04 and support toward $16.73 — roughly +38% from $16.65. Buyers look set to stay in control over this stretch.
Expect SNSE to range from $14.71 to $33.88 through 2028. The $21.44 average target implies a +29% move from current prices. That is -7% versus the projected 2027 average. Momentum favours further upside here.
The SNSE price prediction for 2029 points to an average of $22.48 (low $14.69, high $37.19) — a potential gain of +35% on today's $16.65. Buyers look set to stay in control over this stretch.
In 2030, SNSE is projected to trade between $13.76 and $37.82, averaging $22.00 — a potential gain of +32% from today's $16.65. That is -2% versus the projected 2029 average. Momentum favours further upside here.
Sensei Biotherapeutics, Inc.'s 2031 outlook centres on $18.64, within a $11.19 to $33.13 range. That is -15% versus the projected 2030 average. That marks a +12% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, SNSE could reach as high as $41.67, with a base case around $22.77 and support toward $13.14 — roughly +37% from $16.65. Momentum favours further upside here.
Expect SNSE to range from $15.15 to $51.26 through 2033. The $27.28 average target implies a +64% move from current prices. That is up +20% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SNSE price prediction for 2034 points to an average of $30.06 (low $16.09, high $57.86) — a potential gain of +81% on today's $16.65. Momentum favours further upside here.
In 2035, SNSE is projected to trade between $17.21 and $65.59, averaging $33.33 — a potential gain of +100% from today's $16.65. That is up +11% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Sensei Biotherapeutics, Inc.'s 2040 outlook centres on $43.42, within a $19.54 to $93.63 range. That is up +30% on the projected 2035 average. That marks a +161% change versus current levels. Momentum favours further upside here.
By 2050, SNSE could reach as high as $131.49, with a base case around $57.17 and support toward $25.73 — roughly +243% from $16.65. Buyers look set to stay in control over this stretch.
Investing $1,000 in SNSE today (≈ 60.06006 SNSE) could be worth
$3,433.52
+$2,433.52 (+243%) by 2050 · US Dollar
Based on the average projected SNSE price of $57.17 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SNSEwould be worth at today's price.
$1,000 invested in SNSE on May 27, 2025 (≈ 161.812302 SNSE) would be worth
$2,694.17
+$1,694.17 (+169.4%) today · 2.69× · US Dollar
Based on a SNSE entry price of $6.18 vs. today's $16.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $17.58 | $947.1 | -5.3% |
| 1 month ago | $31.54 | $527.9 | -47.2% |
| 3 months ago | $30.22 | $550.96 | -44.9% |
| 6 months ago | $8.42 | $1,977.43 | +97.7% |
| 1 year ago | $6.18 | $2,694.17 | +169.4% |
| All time (5.0y) ago | $258 | $64.53 | -93.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SNSE forecast.
Our base-case forecast reaches $33.00 around 2035.
Implied market cap at $33.00: $44.28M
Looking across the multi-year forecast, the asset shows a bullish tilt in many years, with rising averages and ROI as time progresses. For 2030 the avg is $23.64 with a min of $14.67 and a max of $40.88, and a projected ROI of 32.9% with bullish sentiment. By 2040 the avg rises to $47.62 and the max to $103.54, with an ROI of 167.7% and bullish sentiment continuing.
By 2050 the avg is $63.73, the max $146.57, and the ROI 258.2% with bullish sentiment. The forecast for earlier years shows fluctuations, such as 2026 min $8.75, avg $17.79, max $24.29 (ROI 0%, neutral) and 2031 avg $20.08, ROI 12.8%. Note that these are estimates, not guarantees, and actual results may vary.
The analysis also highlights high volatility, with annualized volatility at 100%.
Tap a question to reveal the answer.
The 2030 forecast shows a min of $14.67, an avg of $23.64, and a max of $40.88, with an ROI of 32.9% and bullish sentiment.
The forecast points to a bullish outlook in 2027, 2028, 2029, and beyond, with rising averages and ROIs (e.g., 2027 avg $24.82, ROI 39.5%; 2040 ROI 167.7%; 2050 ROI 258.2%). These are estimates, not guarantees.
Yes. The forecasted max reaches $103.54 in 2040 and $146.57 in 2050, indicating that surpassing $100 could occur by 2040 according to the projections.
Current price: $17.79. Market cap: $23.87M. The rank is 4890.
RSI14 is 30 and the sentiment is NEUTRAL. The 50-day SMA is $27.53 and the 200-day SMA is $15.72. Support is at $16.77 and resistance at $32.62, with a 30-day range from $12.62 to $25.07.
Sensei Biotherapeutics, Inc. Community Discussion
0Share your Sensei Biotherapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.